Research in HIV/AIDS doesn't happen in a vacuum. Pharmaceutical companies fund studies. Medical device manufacturers sponsor trials. Researchers hold patents, consult for companies, and sometimes have financial stakes in the technologies they evaluate.
At the International Journal of HIV and AIDS Sciences, we believe readers deserve to know about anything that might have influenced — or could be perceived as influencing — research we publish. Not because we assume bad faith, but because transparency is foundational to trust.
A conflict of interest exists when you have personal, financial, or professional interests that could — or could reasonably be seen to — influence your research, its presentation, or its interpretation.
Here are some common examples, though this list isn't exhaustive:
If you're unsure whether something constitutes a conflict, ask yourself this: Would a reasonable reader feel that this relationship might have influenced my work or judgment — even if I'm confident it didn't? If the answer is yes, or even maybe, disclose it.
All authors must declare any conflicts of interest at the time of submission. This declaration will be published alongside your article if it's accepted.
We ask authors to consider conflicts that existed during the planning, conduct, and writing of the research — not just at the time of submission. Relationships that ended before the study began might still be relevant if they could have influenced your approach.
Failure to disclose relevant conflicts is a serious matter. If undisclosed conflicts come to light after publication, we may need to publish a correction, add a disclosure statement, or in serious cases, consider retraction.
Authors aren't the only ones who can have conflicts. Editors and reviewers bring their own relationships and interests to the table, and these can bias the evaluation process.
Reviewers should decline to evaluate manuscripts if they have a conflict that could affect their judgment. This includes direct competition, collaboration with authors, personal relationships, or financial interests in the research area.
Editors must recuse themselves from handling submissions where they have a conflict. This might mean handing the manuscript to another editor entirely or, at minimum, having no involvement in the decision-making process.
Be specific. "The authors have financial relationships with pharmaceutical companies" tells readers very little. Better: "Author X has received consulting fees from Company Y and holds stock in Company Z, both of which manufacture antiretroviral medications discussed in this paper."
Vague disclosures defeat the purpose. Readers can't assess the potential for bias if they don't know what the actual relationships are.
For more detailed guidance on conflict of interest policies and best practices in publication ethics, we recommend consulting:
The Committee on Publication Ethics (COPE) provides comprehensive guidelines on good publication practice and a Code of Conduct for journal editors.
The International Committee of Medical Journal Editors (ICMJE) offers detailed recommendations on conflicts of interest disclosure, including a standardized disclosure form used by many journals.
If you're unsure whether something needs to be disclosed, or have questions about how to word your declaration, contact us at hiv.publish@gmail.com. When in doubt, disclose.